Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia

被引:33
作者
Watkins-Riedel, T
Stanek, G
Daxboeck, F
机构
[1] Univ Vienna, Allgemeines Krankenhaus Wien, Gen Hosp Vienna, Inst Virol,Div Clin Virol, A-1090 Vienna, Austria
[2] Univ Vienna, Inst Hyg, Div Infect & Immun, A-1095 Vienna, Austria
[3] Univ Hosp Vienna, Dept Internal Med 1, Div Infect Dis & Chemotherapy, A-1090 Vienna, Austria
[4] Karl Franzens Univ Hosp Graz, Dept Internal Med, Div Infect Dis, A-8010 Graz, Austria
关键词
D O I
10.1016/S0732-8893(01)00250-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Acute phase serum samples from 23 patients with Mycoplasma pneumoniae pneumonia were examined for specific antibodies with microparticle agglutination (MAG)-assay, complement fixation (CF)-test, IgM-specific ELISA, and Immunocard-based IgM-EIA. A novel 3-h IgA-ELISA (SeroMP-IgA) was tested to assess its diagnostic value. For MAG, CF, IgM-ELISA, card-based IgM-EIA, and IgA-ELISA positive results were obtained in 87%, 87%, 91%, 87%, and 100%, respectively. Overall concordance was 78%. Specificity testing of 46 healthy blood donors revealed an optimal diagnostic cut-off range of 22-30 IgA-ELISA binding units(BU)/mL resulting in 91%-100% specificity and 100%-96% sensitivity for serologic diagnosis of acute M, pneumoniae infection. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 15 条
[1]   Performance of meridian ImmunoCard Mycoplasma test in a multicenter clinical trial [J].
Alexander, TS ;
Gray, LD ;
Kraft, JA ;
Leland, DS ;
Nikaido, MT ;
Willis, DH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (05) :1180-1183
[2]  
AUBERT G, 1992, ANN BIOL CLIN-PARIS, V50, P593
[3]   EVALUATION OF SERODIA MYCO-II PARTICLE AGGLUTINATION-TEST FOR DETECTING MYCOPLASMA-PNEUMONIAE ANTIBODY - COMPARISON WITH MU-CAPTURE ELISA AND INDIRECT IMMUNOFLUORESCENCE [J].
BARKER, CE ;
SILLIS, M ;
WREGHITT, TG .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (02) :163-165
[4]  
FOY HM, 1993, CLIN INFECT DIS S1, V17, P37
[5]   Prospective study of epidemiology and prognostic factors in community-acquired pneumonia [J].
Gomez, J ;
Banos, V ;
Gomez, JR ;
Soto, MC ;
Munoz, L ;
Nunez, ML ;
Canteras, M ;
Valdes, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (07) :556-560
[6]   THE ROLE OF ISA DETERMINATION BY ELISA IN THE EARLY SERODIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION, IN RELATION TO IGG AND MU-CAPTURE IGM METHODS [J].
GRANSTROM, M ;
HOLME, T ;
SJOGREN, AM ;
ORTQVIST, A ;
KALIN, M .
JOURNAL OF MEDICAL MICROBIOLOGY, 1994, 40 (04) :288-292
[7]   REACTION PATTERN OF HUMAN ANTI-MYCOPLASMA-PNEUMONIAE ANTIBODIES IN ENZYME-LINKED IMMUNOSORBENT ASSAYS AND IMMUNOBLOTTING [J].
JACOBS, E ;
BENNEWITZ, A ;
BREDT, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (03) :517-522
[8]   Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma [J].
Kraft, M ;
Cassell, GH ;
Henson, JE ;
Watson, H ;
Williamson, J ;
Marmion, BP ;
Gaydos, CA ;
Martin, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) :998-1001
[9]  
Lieberman D, 1996, RESPIRATION, V63, P261
[10]   Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course [J].
Marrie, TJ ;
Peeling, RW ;
Fine, MJ ;
Singer, DE ;
Coley, CM ;
Kapoor, WN .
AMERICAN JOURNAL OF MEDICINE, 1996, 101 (05) :508-515